Name | Pentanamide, N-(1-cyanocyclopropyl)-2-[[(1S)-1-[4'-[(1R)-2,2-difluoro-1-hydroxyethyl][1,1'-biphenyl]-4-yl]-2,2,2-trifluoroethyl]amino]-4-fluoro-4-methyl-, (2S) |
---|
Description | MK-0674 is a potent, orally bioavailable and selective cathepsin K inhibitor, with an IC50 of 0.4 nM, shows 1156, 1465, 11857 and 243 fold selectivity over Cat B, Cat F, Cat L and Cat S. MK-0674 exhibits long half-lives in rats, rabbits and rhesus monkeys[1]. |
---|---|
Related Catalog | |
Target |
IC50: 0.4 nM (Cathepsin K)[1] |
In Vitro | MK-0674 (Compound 13) is potent in bone resorption in rabbit osteoclasts, with an IC50 of 10 nM[1]. |
References |
Molecular Formula | C26H27F6N3O2 |
---|---|
Molecular Weight | 527.50200 |
Exact Mass | 527.20100 |
PSA | 85.15000 |
LogP | 6.30608 |